{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T14:03:50Z","timestamp":1761314630104,"version":"build-2065373602"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T00:00:00Z","timestamp":1761264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T00:00:00Z","timestamp":1761264000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82301446","82101350","82171188"],"award-info":[{"award-number":["82301446","82101350","82171188"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["23Y21900600"],"award-info":[{"award-number":["23Y21900600"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Anesthesiol"],"DOI":"10.1186\/s12871-025-03398-z","type":"journal-article","created":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T14:00:25Z","timestamp":1761314425000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Effect of sugammadex titration versus manufacturer\u2019s recommendation for reversal of rocuronium-induced neuromuscular block: a prospective, randomized, controlled trial"],"prefix":"10.1186","volume":"25","author":[{"given":"Lingqi","family":"Gao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bing","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingjing","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuran","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiazheng","family":"Qi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tingting","family":"Gu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenxiang","family":"Bao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhoujing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bingyan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mengqiang","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiong","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingwei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,24]]},"reference":[{"issue":"8","key":"3398_CR1","first-page":"CD012763","volume":"8","author":"AM Hristovska","year":"2017","unstructured":"Hristovska AM, Duch P, Allingstrup M, Afshari A. Efficacy and safety of Sugammadex versus neostigmine in reversing neuromuscular Blockade in adults. Cochrane Database Syst Rev. 2017;8(8):CD012763.","journal-title":"Cochrane Database Syst Rev"},{"issue":"9","key":"3398_CR2","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1111\/j.1365-2044.2012.07197.x","volume":"67","author":"G Geldner","year":"2012","unstructured":"Geldner G, Niskanen M, Laurila P, et al. A randomised controlled trial comparing Sugammadex and neostigmine at different depths of neuromuscular blockade in patients undergoing laparoscopic surgery. Anaesthesia. 2012;67(9):991\u20138.","journal-title":"Anaesthesia"},{"issue":"6","key":"3398_CR3","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1097\/ALN.0000000000003256","volume":"132","author":"S Kheterpal","year":"2020","unstructured":"Kheterpal S, Vaughn MT, Dubovoy TZ, et al. Sugammadex versus neostigmine for reversal of neuromuscular blockade and postoperative pulmonary complications (STRONGER): a multicenter matched cohort analysis. Anesthesiology. 2020;132(6):1371\u201381.","journal-title":"Anesthesiology"},{"issue":"19","key":"3398_CR4","doi-asserted-by":"publisher","first-page":"e575","DOI":"10.1093\/ajhp\/zxae124","volume":"81","author":"DD Linn","year":"2024","unstructured":"Linn DD, Renew JR. The impact of Sugammadex dosing and administration practices on potential cost savings for pharmacy departments. Am J Health Syst Pharm. 2024;81(19):e575\u201383.","journal-title":"Am J Health Syst Pharm"},{"issue":"3","key":"3398_CR5","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1097\/ALN.0000000000001744","volume":"127","author":"L Asztalos","year":"2017","unstructured":"Asztalos L, Szab\u00f3-Ma\u00e1k Z, Gajdos A, et al. Reversal of vecuronium-induced neuromuscular blockade with low-dose sugammadex at train-of-four count of four: a randomized controlled trial. Anesthesiology. 2017;127(3):441\u20139.","journal-title":"Anesthesiology"},{"issue":"1","key":"3398_CR6","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1097\/ALN.0b013e318297ce95","volume":"119","author":"A Pongr\u00e1cz","year":"2013","unstructured":"Pongr\u00e1cz A, Szatm\u00e1ri S, Nemes R, F\u00fclesdi B, Tassonyi E. Reversal of neuromuscular blockade with Sugammadex at the reappearance of four twitches to train-of-four stimulation. Anesthesiology. 2013;119(1):36\u201342.","journal-title":"Anesthesiology"},{"issue":"8","key":"3398_CR7","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1097\/EJA.0000000000001502","volume":"38","author":"O Duranteau","year":"2021","unstructured":"Duranteau O, Fernandez W, Tuna T, Engelman E, Van Obbergh L, Tabolcea I. Earlier and lower dose administration of sugammadex: a randomised placebo-controlled trial. Eur J Anaesthesiol. 2021;38(8):865\u201371.","journal-title":"Eur J Anaesthesiol"},{"issue":"5","key":"3398_CR8","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1093\/bja\/aeq226","volume":"105","author":"FK P\u00fchringer","year":"2010","unstructured":"P\u00fchringer FK, Gordon M, Demeyer I, et al. Sugammadex rapidly reverses moderate rocuronium- or vecuronium-induced neuromuscular block during sevoflurane anaesthesia: a dose-response relationship. Br J Anaesth. 2010;105(5):610\u20139.","journal-title":"Br J Anaesth"},{"issue":"1","key":"3398_CR9","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1213\/ANE.0b013e3181c3be3c","volume":"110","author":"P Duvaldestin","year":"2010","unstructured":"Duvaldestin P, Kuizenga K, Saldien V, et al. A randomized, dose-response study of Sugammadex given for the reversal of deep rocuronium- or vecuronium-induced neuromuscular blockade under Sevoflurane anesthesia. Anesth Analg. 2010;110(1):74\u201382.","journal-title":"Anesth Analg"},{"issue":"3","key":"3398_CR10","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.bja.2023.12.001","volume":"132","author":"JM Hunter","year":"2024","unstructured":"Hunter JM, Blobner M. Under-dosing and over-dosing of neuromuscular blocking drugs and reversal agents: beware of the risks. Br J Anaesth. 2024;132(3):461\u20135.","journal-title":"Br J Anaesth"},{"issue":"2","key":"3398_CR11","doi-asserted-by":"publisher","first-page":"1988","DOI":"10.1097\/JS9.0000000000002194","volume":"111","author":"H Liu","year":"2025","unstructured":"Liu H, Yang Q, Li Z, et al. Systematic analysis of sugammadex-related adverse drug reaction signals using FAERS database. Int J Surg. 2025;111(2):1988\u201394.","journal-title":"Int J Surg"},{"issue":"1","key":"3398_CR12","doi-asserted-by":"publisher","first-page":"95","DOI":"10.4097\/kjae.2017.70.1.95","volume":"70","author":"JH Lee","year":"2017","unstructured":"Lee JH, Lee JH, Lee MH, Cho HO, Park SE. Postoperative negative pressure pulmonary edema following repetitive laryngospasm even after reversal of neuromuscular blockade by sugammadex: a case report. Korean J Anesthesiol. 2017;70(1):95\u20139.","journal-title":"Korean J Anesthesiol"},{"issue":"2","key":"3398_CR13","doi-asserted-by":"publisher","first-page":"117","DOI":"10.17085\/apm.2019.14.2.117","volume":"14","author":"W Lee","year":"2019","unstructured":"Lee W. The potential risks of Sugammadex. Anesth Pain Med. 2019;14(2):117\u201322.","journal-title":"Anesth Pain Med"},{"issue":"12","key":"3398_CR14","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1097\/EJA.0000000000000082","volume":"31","author":"JR Ortiz-G\u00f3mez","year":"2014","unstructured":"Ortiz-G\u00f3mez JR, Palacio-Abizanda FJ, Fornet-Ruiz I. Failure of sugammadex to reverse rocuronium-induced neuromuscular blockade: a case report. Eur J Anaesthesiol. 2014;31(12):708\u20139.","journal-title":"Eur J Anaesthesiol"},{"issue":"1","key":"3398_CR15","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1097\/ALN.0000000000004578","volume":"139","author":"TA Bowdle","year":"2023","unstructured":"Bowdle TA, Haththotuwegama KJ, Jelacic S, Nguyen ST, Togashi K, Michaelsen KE. A dose-finding study of Sugammadex for reversal of Rocuronium in cardiac surgery patients and postoperative monitoring for recurrent paralysis. Anesthesiology. 2023;139(1):6\u201315.","journal-title":"Anesthesiology"},{"key":"3398_CR16","doi-asserted-by":"publisher","first-page":"e081124","DOI":"10.1136\/bmj-2024-081124","volume":"388","author":"S Hopewell","year":"2025","unstructured":"Hopewell S, Chan AW, Collins GS, Hr\u00f3bjartsson A, Moher D, Schulz KF, et al. CONSORT 2025 explanation and elaboration: updated guideline for reporting randomised trials. BMJ. 2025;388:e081124.","journal-title":"BMJ"},{"issue":"8","key":"3398_CR17","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1111\/aas.14279","volume":"67","author":"T Fuchs-Buder","year":"2023","unstructured":"Fuchs-Buder T, Brull SJ, Fagerlund MJ, et al. Good clinical research practice (GCRP) in pharmacodynamic studies of neuromuscular blocking agents III: the 2023 Geneva revision. Acta Anaesthesiol Scand. 2023;67(8):994\u20131017.","journal-title":"Acta Anaesthesiol Scand"},{"key":"3398_CR18","doi-asserted-by":"publisher","first-page":"9","DOI":"10.2147\/IJGM.S424555","volume":"17","author":"P Radkowski","year":"2024","unstructured":"Radkowski P, Bara\u0144ska A, Mieszkowski M, Dawidowska-Fidrych J, Podhorodecka K. Methods for clinical monitoring of neuromuscular transmission in anesthesiology - a review. Int J Gen Med. 2024;17:9\u201320.","journal-title":"Int J Gen Med"},{"issue":"4","key":"3398_CR19","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.ijoa.2015.08.012","volume":"24","author":"L Gao","year":"2015","unstructured":"Gao L, Zheng G, Han J, Wang Y, Zheng J. Effects of prophylactic ondansetron on spinal anesthesia-induced hypotension: a meta-analysis. Int J Obstet Anesth. 2015;24(4):335\u201343.","journal-title":"Int J Obstet Anesth"},{"issue":"1","key":"3398_CR20","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1093\/bja\/aei273","volume":"96","author":"T Suzuki","year":"2006","unstructured":"Suzuki T, Fukano N, Kitajima O, Saeki S, Ogawa S. Normalization of acceleromyographic train-of-four ratio by baseline value for detecting residual neuromuscular block. Br J Anaesth. 2006;96(1):44\u20137.","journal-title":"Br J Anaesth"},{"issue":"4","key":"3398_CR21","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1097\/ALN.0b013e3181cded07","volume":"112","author":"B Plaud","year":"2010","unstructured":"Plaud B, Debaene B, Donati F, Marty J. Residual paralysis after emergence from anesthesia. Anesthesiology. 2010;112(4):1013\u201322.","journal-title":"Anesthesiology"},{"issue":"2","key":"3398_CR22","doi-asserted-by":"publisher","first-page":"e73","DOI":"10.1213\/ANE.0000000000004761","volume":"131","author":"SR Thilen","year":"2020","unstructured":"Thilen SR, Weigel WA. Sugammadex: a costly simple solution that is not really solving the problem. Anesth Analg. 2020;131(2):e73-4.","journal-title":"Anesth Analg"},{"issue":"19","key":"3398_CR23","doi-asserted-by":"publisher","first-page":"2140","DOI":"10.2174\/1381612825666190704101145","volume":"25","author":"J Hawkins","year":"2019","unstructured":"Hawkins J, Khanna S, Argalious M. Sugammadex for reversal of neuromuscular blockade: uses and limitations. Curr Pharm Des. 2019;25(19):2140\u20138.","journal-title":"Curr Pharm Des"},{"issue":"1","key":"3398_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/s12871-018-0605-6","volume":"18","author":"HD de Boer","year":"2018","unstructured":"de Boer HD, Carlos RV, Brull SJ. Is lower-dose Sugammadex a cost-saving strategy for reversal of deep neuromuscular block? Facts and fiction. BMC Anesthesiol. 2018;18(1):159.","journal-title":"BMC Anesthesiol"},{"issue":"5","key":"3398_CR25","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1097\/ALN.0b013e3181f4182a","volume":"113","author":"SJ Schaller","year":"2010","unstructured":"Schaller SJ, Fink H, Ulm K, Blobner M. Sugammadex and neostigmine dose-finding study for reversal of shallow residual neuromuscular block. Anesthesiology. 2010;113(5):1054\u201360.","journal-title":"Anesthesiology"},{"issue":"4","key":"3398_CR26","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1097\/00000542-200604000-00009","volume":"104","author":"IF Sorgenfrei","year":"2006","unstructured":"Sorgenfrei IF, Norrild K, Larsen PB, et al. Reversal of rocuronium-induced neuromuscular block by the selective relaxant binding agent sugammadex: a dose-finding and safety study. Anesthesiology. 2006;104(4):667\u201374.","journal-title":"Anesthesiology"},{"issue":"10","key":"3398_CR27","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1007\/s12630-011-9554-y","volume":"58","author":"F Le Corre","year":"2011","unstructured":"Le Corre F, Nejmeddine S, Fatahine C, Tayar C, Marty J, Plaud B. Recurarization after Sugammadex reversal in an obese patient. Can J Anaesth. 2011;58(10):944\u20137.","journal-title":"Can J Anaesth"},{"issue":"5","key":"3398_CR28","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1093\/bja\/85.5.717","volume":"85","author":"JH Proost","year":"2000","unstructured":"Proost JH, Eriksson LI, Mirakhur RK, Roest G, Wierda JM. Urinary, biliary and faecal excretion of Rocuronium in humans. Br J Anaesth. 2000;85(5):717\u201323.","journal-title":"Br J Anaesth"},{"issue":"8","key":"3398_CR29","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1592\/phco.27.8.1181","volume":"27","author":"WT Nicholson","year":"2007","unstructured":"Nicholson WT, Sprung J, Jankowski CJ. Sugammadex: a novel agent for the reversal of neuromuscular blockade. Pharmacotherapy. 2007;27(8):1181\u20138.","journal-title":"Pharmacotherapy"},{"key":"3398_CR30","doi-asserted-by":"crossref","unstructured":"Brull SJ, Murphy GS. Residual neuromuscular block: lessons Unlearned. Part II. Anesth Analgesia. 2010;111(1):129\u201340.","DOI":"10.1213\/ANE.0b013e3181da8312"},{"issue":"3","key":"3398_CR31","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.bja.2023.05.019","volume":"131","author":"J Poelaert","year":"2023","unstructured":"Poelaert J, Hunter JM. Educating anaesthetists on neuromuscular monitoring: the challenges continue. Br J Anaesth. 2023;131(3):429\u201331.","journal-title":"Br J Anaesth"},{"issue":"1","key":"3398_CR32","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1097\/ALN.0000000000004379","volume":"138","author":"SR Thilen","year":"2023","unstructured":"Thilen SR, Weigel WA, Todd MM, et al. 2023 American society of anesthesiologists practice guidelines for monitoring and antagonism of neuromuscular blockade: a report by the American society of anesthesiologists task force on neuromuscular blockade. Anesthesiology. 2023;138(1):13\u201341.","journal-title":"Anesthesiology"},{"issue":"4","key":"3398_CR33","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1093\/bja\/aer495","volume":"108","author":"AA Dahaba","year":"2012","unstructured":"Dahaba AA, Bornemann H, Hopfgartner E, et al. Effect of sugammadex or neostigmine neuromuscular block reversal on bispectral index monitoring of propofol\/remifentanil anaesthesia. Br J Anaesth. 2012;108(4):602\u20136.","journal-title":"Br J Anaesth"},{"issue":"10","key":"3398_CR34","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1111\/anae.13960","volume":"72","author":"CR Bailey","year":"2017","unstructured":"Bailey CR. Sugammadex: when should we be giving it? Anaesthesia. 2017;72(10):1170\u20135.","journal-title":"Anaesthesia"},{"issue":"5","key":"3398_CR35","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1097\/00000542-200305000-00004","volume":"98","author":"B Debaene","year":"2003","unstructured":"Debaene B, Plaud B, Dilly MP, Donati F. Residual paralysis in the PACU after a single intubating dose of nondepolarizing muscle relaxant with an intermediate duration of action. Anesthesiology. 2003;98(5):1042\u20138.","journal-title":"Anesthesiology"},{"issue":"1","key":"3398_CR36","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1111\/j.1365-2044.2006.04862.x","volume":"62","author":"DM Maybauer","year":"2007","unstructured":"Maybauer DM, Geldner G, Blobner M, et al. Incidence and duration of residual paralysis at the end of surgery after multiple administrations of cisatracurium and Rocuronium. Anaesthesia. 2007;62(1):12\u20137.","journal-title":"Anaesthesia"},{"issue":"suppl1","key":"3398_CR37","doi-asserted-by":"publisher","first-page":"i53","DOI":"10.1093\/bja\/aex318","volume":"119","author":"JM Hunter","year":"2017","unstructured":"Hunter JM. Reversal of residual neuromuscular block: complications associated with perioperative management of muscle relaxation. Br J Anaesth. 2017;119(suppl1):i53-62.","journal-title":"Br J Anaesth"}],"container-title":["BMC Anesthesiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12871-025-03398-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12871-025-03398-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12871-025-03398-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T14:00:26Z","timestamp":1761314426000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcanesthesiol.biomedcentral.com\/articles\/10.1186\/s12871-025-03398-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,24]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3398"],"URL":"https:\/\/doi.org\/10.1186\/s12871-025-03398-z","relation":{},"ISSN":["1471-2253"],"issn-type":[{"value":"1471-2253","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,24]]},"assertion":[{"value":"28 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki and approved by the institutional ethics committee (No.2023822, Huashan Hospital, Fudan University, Shanghai, China) on September 13, 2023. All the participants gave their written informed consent to participate in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"521"}}